{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:49:53Z","timestamp":1787759393201,"version":"build-2784847793"},"reference-count":44,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Laboratory Medicine"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.cll.2024.10.006","type":"journal-article","created":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T02:06:51Z","timestamp":1731722811000},"page":"51-61","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Carbapenemase Mechanism Testing to Support Treatment, Infection Control, and Public Health"],"prefix":"10.1016","volume":"45","author":[{"given":"Sara J.","family":"Blosser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia S.","family":"Bhatnagar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Bollinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha R.","family":"Giffen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cll.2024.10.006_bib1","series-title":"Antibiotic resistance threats in the United States, 2019","year":"2019"},{"key":"10.1016\/j.cll.2024.10.006_bib2","author":"Laboratories"},{"key":"10.1016\/j.cll.2024.10.006_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.jgar.2024.03.020","article-title":"Global trends in carbapenem- and difficult-to-treat-resistance among World Health Organization priority bacterial pathogens: ATLAS surveillance program 2018-2022","author":"Wise","year":"2024","journal-title":"J\u00a0Glob Antimicrob Resist"},{"issue":"9","key":"10.1016\/j.cll.2024.10.006_bib4","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1017\/ice.2018.153","article-title":"Hospital microbiology laboratory practices for enterobacteriaceae: Centers for Disease control and prevention national healthcare safety network (NHSN) annual survey, 2015 and 2016","volume":"39","author":"Shugart","year":"2018","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"6","key":"10.1016\/j.cll.2024.10.006_bib6","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S1473-3099(19)30755-8","article-title":"Molecular and clinical epidemiology of carbapenem-resistant Enterobacterales in the USA (CRACKLE-2): a prospective cohort study","volume":"20","author":"van Duin","year":"2020","journal-title":"Lancet Infect Dis"},{"issue":"12","key":"10.1016\/j.cll.2024.10.006_bib8","doi-asserted-by":"crossref","first-page":"e0110521","DOI":"10.1128\/AAC.01105-21","article-title":"Detection and characterization of targeted carbapenem-resistant health care-associated threats: findings from the antibiotic resistance laboratory network, 2017 to 2019","volume":"65","author":"Sabour","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"issue":"23","key":"10.1016\/j.cll.2024.10.006_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21239308","article-title":"New carbapenemase inhibitors: clearing the way for the beta-lactams","volume":"21","author":"Vazquez-Ucha","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.cll.2024.10.006_bib10","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1128\/AAC.03042-15","article-title":"In\u00a0vitro susceptibility to ceftazidime-avibactam of carbapenem-nonsusceptible enterobacteriaceae isolates collected during the INFORM global surveillance study (2012 to 2014)","volume":"60","author":"de Jonge","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.cll.2024.10.006_bib11","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1093\/jac\/dkac425","article-title":"Phenotypes, genotypes and breakpoints: an assessment of beta-lactam\/beta-lactamase inhibitor combinations against OXA-48","volume":"78","author":"Asempa","year":"2023","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cll.2024.10.006_bib12","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciad428","article-title":"Infectious Diseases Society of America 2023 guidance on the treatment of antimicrobial resistant gram-negative infections","author":"Tamma","year":"2023","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cll.2024.10.006_bib13","series-title":"Analysis and presentation of cumulative antimicrobial susceptibility test data","first-page":"2022","year":"2022"},{"issue":"8","key":"10.1016\/j.cll.2024.10.006_bib14","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00796-17","article-title":"Comparison of two phenotypic algorithms to detect carbapenemase-producing enterobacteriaceae","volume":"61","author":"Dortet","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"10.1016\/j.cll.2024.10.006_bib15","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00499-20","article-title":"Antibiotic susceptibility of NDM-producing enterobacterales collected in the United States in 2017 and 2018","volume":"64","author":"Lutgring","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.cll.2024.10.006_bib16","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1093\/jac\/dkz456","article-title":"In\u00a0vitro activity of ceftazidime\/avibactam against isolates of carbapenem-non-susceptible Enterobacteriaceae collected during the INFORM global surveillance programme (2015-17)","volume":"75","author":"Spiliopoulou","year":"2020","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"11","key":"10.1016\/j.cll.2024.10.006_bib17","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01443-17","article-title":"Vaborbactam: spectrum of beta-lactamase inhibition and impact of resistance mechanisms on activity in enterobacteriaceae","volume":"61","author":"Lomovskaya","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.cll.2024.10.006_bib18","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.bmcl.2013.12.101","article-title":"Discovery of MK-7655, a beta-lactamase inhibitor for combination with Primaxin(R)","volume":"24","author":"Blizzard","year":"2014","journal-title":"Bioorg Med Chem Lett"},{"issue":"6","key":"10.1016\/j.cll.2024.10.006_bib19","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1093\/cid\/ciac078","article-title":"Cefiderocol for the treatment of infections due to metallo-B-lactamase-producing pathogens in the CREDIBLE-CR and APEKS-NP phase 3 randomized studies","volume":"75","author":"Timsit","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.cll.2024.10.006_bib20","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1093\/jac\/dkx496","article-title":"Clinical outcomes after combination treatment with ceftazidime\/avibactam and aztreonam for NDM-1\/OXA-48\/CTX-M-15-producing Klebsiella pneumoniae infection","volume":"73","author":"Shaw","year":"2018","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"12","key":"10.1016\/j.cll.2024.10.006_bib21","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1093\/cid\/ciac354","article-title":"Impact of a rapid molecular test for klebsiella pneumoniae carbapenemase and ceftazidime-avibactam use on outcomes after bacteremia caused by carbapenem-resistant enterobacterales","volume":"75","author":"Satlin","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.cll.2024.10.006_bib22","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1111\/j.1469-0691.2011.03514.x","article-title":"Predictors of mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment","volume":"17","author":"Zarkotou","year":"2011","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"10.1016\/j.cll.2024.10.006_bib23","doi-asserted-by":"crossref","first-page":"2179344","DOI":"10.1080\/22221751.2023.2179344","article-title":"Directed carbapenemase testing is no longer just for Enterobacterales: cost, labor, and workflow assessment of expanding carbapenemase testing to carbapenem-resistant P. aeruginosa","volume":"12","author":"Gill","year":"2023","journal-title":"Emerg Microb Infect"},{"key":"10.1016\/j.cll.2024.10.006_bib24","first-page":"21","article-title":"Interim guidance for public health strategies to prevent the spread of novel or targeted multidrug-resistant organisms","year":"2023","journal-title":"MDROs)"},{"key":"10.1016\/j.cll.2024.10.006_bib25","first-page":"24","article-title":"Interim guidance for a public health response to contain novel or targeted multidrug-resistant organisms","year":"2022","journal-title":"MDROs)"},{"issue":"10","key":"10.1016\/j.cll.2024.10.006_bib28","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1017\/ice.2015.163","article-title":"Modeling spread of KPC-producing bacteria in long-term acute care hospitals in the Chicago region, USA","volume":"36","author":"Haverkate","year":"2015","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"11","key":"10.1016\/j.cll.2024.10.006_bib29","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1093\/infdis\/jiz288","article-title":"Knowing more of the iceberg: how detecting a greater proportion of carbapenem-resistant enterobacteriaceae carriers influences transmission","volume":"221","author":"Bartsch","year":"2020","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.cll.2024.10.006_bib30","unstructured":"CDC, Biennial overview of post-acute and long-term care in the United States, Available at: https:\/\/www.cdc.gov\/nchs\/npals\/webtables\/overview.htm#technical-notes. (Accessed 20 May 2024), 2021."},{"issue":"15","key":"10.1016\/j.cll.2024.10.006_bib35","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa1007474","article-title":"Veterans affairs initiative to prevent methicillin-resistant Staphylococcus aureus infections","volume":"364","author":"Jain","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.cll.2024.10.006_bib36","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1086\/382886","article-title":"Projected benefits of active surveillance for vancomycin-resistant enterococci in intensive care units","volume":"38","author":"Perencevich","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.cll.2024.10.006_bib37","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1001\/jamainternmed.2016.0177","article-title":"Effect of detecting and isolating clostridium difficile carriers at hospital admission on the incidence of C difficile infections: a quasi-experimental controlled study","volume":"176","author":"Longtin","year":"2016","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.cll.2024.10.006_bib38","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/1471-2334-13-68","article-title":"Multidrug-resistant gram-negative bacteria colonization of healthy US military personnel in the US and Afghanistan","volume":"13","author":"Vento","year":"2013","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.cll.2024.10.006_bib39","series-title":"Assessing genomic sequencing information for health care decision making: workshop summary","year":"2014"},{"issue":"2","key":"10.1016\/j.cll.2024.10.006_bib40","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1128\/AAC.49.2.798-800.2005","article-title":"Test characteristics of perirectal and rectal swab compared to stool sample for detection of fluoroquinolone-resistant Escherichia coli in the gastrointestinal tract","volume":"49","author":"Lautenbach","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"10.1016\/j.cll.2024.10.006_bib41","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1086\/668027","article-title":"Sites of colonization with extended-spectrum beta-lactamases (ESBL)-producing enterobacteriaceae: the rationale for screening","volume":"33","author":"Tschudin-Sutter","year":"2012","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"1","key":"10.1016\/j.cll.2024.10.006_bib42","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1086\/668783","article-title":"Anatomic sites of patient colonization and environmental contamination with Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae at long-term acute care hospitals","volume":"34","author":"Thurlow","year":"2013","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.cll.2024.10.006_bib43","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s13756-018-0434-x","article-title":"The acceptability of screening for Carbapenemase Producing Enterobacteriaceae (CPE): cross-sectional survey of nursing staff and the general publics' perceptions","volume":"7","author":"Currie","year":"2018","journal-title":"Antimicrob Resist Infect Control"},{"issue":"21\u201322","key":"10.1016\/j.cll.2024.10.006_bib44","doi-asserted-by":"crossref","first-page":"3890","DOI":"10.1111\/jocn.14982","article-title":"Patient experience of hospital screening for carbapenemase-producing enterobacteriaceae: a qualitative study","volume":"28","author":"King","year":"2019","journal-title":"J\u00a0Clin Nurs"},{"issue":"8","key":"10.1016\/j.cll.2024.10.006_bib45","doi-asserted-by":"crossref","first-page":"577 e1","DOI":"10.1016\/j.cmi.2017.02.019","article-title":"Efficacy and acceptability of rectal and perineal sampling for identifying gastrointestinal colonization with extended spectrum beta-lactamase Enterobacteriaceae","volume":"23","author":"Dyakova","year":"2017","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cll.2024.10.006_bib46","series-title":"Performance standards for antimicrobial susceptibility testing","year":"2024"},{"key":"10.1016\/j.cll.2024.10.006_bib47","unstructured":"EUCAST. EUCAST guidelines for detection of resistance mechanisms and specific resistances of clinical and\/or epidemiological importance. Version 2.0. 2017."},{"issue":"2","key":"10.1016\/j.cll.2024.10.006_bib48","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.jmoldx.2019.10.004","article-title":"Evaluation of the BD MAX check-points CPO assay for the detection of carbapenemase producers directly from rectal swabs","volume":"22","author":"Girlich","year":"2020","journal-title":"J\u00a0Mol Diagn"},{"key":"10.1016\/j.cll.2024.10.006_bib49","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.mimet.2016.03.001","article-title":"The implications of endemic IMP-4 carbapenemase for clinical laboratory susceptibility testing","volume":"124","author":"Goire","year":"2016","journal-title":"J\u00a0Microbiol Methods"},{"issue":"4","key":"10.1016\/j.cll.2024.10.006_bib50","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01927-19","article-title":"Evaluation of the revogene carba C assay for detection and differentiation of carbapenemase-producing gram-negative bacteria","volume":"58","author":"Girlich","year":"2020","journal-title":"J\u00a0Clin Microbiol"},{"issue":"3","key":"10.1016\/j.cll.2024.10.006_bib51","doi-asserted-by":"crossref","first-page":"e0079323","DOI":"10.1128\/spectrum.00793-23","article-title":"Evaluation of the NG-test CARBA 5 lateral flow assay with an IMP-27-producing morganella morganii and other morganellaceae","volume":"11","author":"Tarlton","year":"2023","journal-title":"Microbiol Spectr"},{"issue":"9","key":"10.1016\/j.cll.2024.10.006_bib52","doi-asserted-by":"crossref","first-page":"1019 e5","DOI":"10.1016\/j.cmi.2018.02.018","article-title":"bla(IMP-27) on transferable plasmids in Proteus mirabilis and Providencia rettgeri","volume":"24","author":"Potter","year":"2018","journal-title":"Clin Microbiol Infect"}],"container-title":["Clinics in Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272271224000696?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272271224000696?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T18:08:06Z","timestamp":1749578886000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272271224000696"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S0272271224000696"],"URL":"https:\/\/doi.org\/10.1016\/j.cll.2024.10.006","relation":{},"ISSN":["0272-2712"],"issn-type":[{"value":"0272-2712","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Carbapenemase Mechanism Testing to Support Treatment, Infection Control, and Public Health","name":"articletitle","label":"Article Title"},{"value":"Clinics in Laboratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cll.2024.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}